Evidence map›Paper›PMID 38307878›Full record

ArticleScientific reports2024

Malaria seroepidemiology in very low transmission settings in the Peruvian Amazon.

Bryan Fernandez-Camacho, Brian Peña-Calero, Martina Guillermo-Roman, Jorge Ruiz-Cabrejos, Jose Luis Barboza, Lucia Bartolini-Arana, Antony Barja-Ingaruca, Hugo Rodriguez-Ferrucci, Veronica E Soto-Calle, Luca Nelli and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Mapping residual malaria transmission in Vietnam.The Lancet regional health. Western Pacific · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Bryan Fernandez-CamachoHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru. bryan.fernandez.c@upch.pe.
Brian Peña-CaleroHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Martina Guillermo-RomanHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Jorge Ruiz-CabrejosHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Jose Luis BarbozaHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Lucia Bartolini-AranaHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Antony Barja-IngarucaHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Hugo Rodriguez-FerrucciUniversidad Nacional de La Amazonía Peruana, Loreto, Peru.
Veronica E Soto-CalleInstitute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Luca NelliDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Isabel ByrneDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Monica HillUniversity of Surrey, Guildford, UK.
Elin DumontDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Lynn GrignardDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Kevin TettehDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Lindsey WuDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Alejandro Llanos-CuentasInstitute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Chris DrakeleyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Gillian StresmanDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Gabriel Carrasco-EscobarHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.

Funding

Bill and Melinda Gates Foundation OPP1177272
6 · The paper itself

Abstract

Despite progress towards malaria reduction in Peru, measuring exposure in low transmission areas is crucial for achieving elimination. This study focuses on two very low transmission areas in Loreto (Peruvian Amazon) and aims to determine the relationship between malaria exposure and proximity to health facilities. Individual data was collected from 38 villages in Indiana and Belen, including geo-referenced households and blood samples for microscopy, PCR and serological analysis. A segmented linear regression model identified significant changes in seropositivity trends among different age groups. Local Getis-Ord Gi* statistic revealed clusters of households with high (hotspots) or low (coldspots) seropositivity rates. Findings from 4000 individuals showed a seropositivity level of 2.5% (95%CI: 2.0%-3.0%) for P. falciparum and 7.8% (95%CI: 7.0%-8.7%) for P. vivax, indicating recent or historical exposure. The segmented regression showed exposure reductions in the 40-50 age group (β1 = 0.043, p = 0.003) for P. vivax and the 50-60 age group (β1 = 0.005, p = 0.010) for P. falciparum. Long and extreme distance villages from Regional Hospital of Loreto exhibited higher malaria exposure compared to proximate and medium distance villages (p < 0.001). This study showed the seropositivity of malaria in two very low transmission areas and confirmed the spatial pattern of hotspots as villages become more distant.

Indexed as

MalariaMalaria, FalciparumMalaria, VivaxHumansPeruPlasmodium falciparumPlasmodium vivaxSeroepidemiologic Studies

Identifiers

PMID38307878
PMCPMC10837415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.